company background image
526783 logo

Dr. Agarwal's Eye Hospital BSE:526783 Stock Report

Last Price

₹3.28k

Market Cap

₹15.3b

7D

-0.5%

1Y

183.4%

Updated

19 Apr, 2024

Data

Company Financials

Dr. Agarwal's Eye Hospital Limited

BSE:526783 Stock Report

Market Cap: ₹15.3b

526783 Stock Overview

Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, Nigeria, and Mauritius.

526783 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health2/6
Dividends3/6

Dr. Agarwal's Eye Hospital Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dr. Agarwal's Eye Hospital
Historical stock prices
Current Share Price₹3,282.00
52 Week High₹3,550.00
52 Week Low₹1,113.10
Beta0.20
1 Month Change9.97%
3 Month Change9.29%
1 Year Change183.42%
3 Year Change938.28%
5 Year Change821.91%
Change since IPO46,785.71%

Recent News & Updates

Recent updates

Shareholder Returns

526783IN HealthcareIN Market
7D-0.5%-4.1%-2.5%
1Y183.4%61.1%44.5%

Return vs Industry: 526783 exceeded the Indian Healthcare industry which returned 61.1% over the past year.

Return vs Market: 526783 exceeded the Indian Market which returned 44.5% over the past year.

Price Volatility

Is 526783's price volatile compared to industry and market?
526783 volatility
526783 Average Weekly Movement4.6%
Healthcare Industry Average Movement6.3%
Market Average Movement6.9%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 526783 has not had significant price volatility in the past 3 months.

Volatility Over Time: 526783's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1957974Amar Agarwalwww.dragarwal.com

Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, Nigeria, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrome, hypertensive retinopathy, black fungus, traumatic cataract, keratoconus, uveitis, pterygium, blepharitis, posterior subcapsular cataract, rosette cataract, and congenital glaucoma. Dr. Agarwal's Eye Hospital Limited was founded in 1957 and is based in Chennai, India.

Dr. Agarwal's Eye Hospital Limited Fundamentals Summary

How do Dr. Agarwal's Eye Hospital's earnings and revenue compare to its market cap?
526783 fundamental statistics
Market cap₹15.28b
Earnings (TTM)₹472.50m
Revenue (TTM)₹3.06b

32.6x

P/E Ratio

5.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
526783 income statement (TTM)
Revenue₹3.06b
Cost of Revenue₹1.13b
Gross Profit₹1.93b
Other Expenses₹1.45b
Earnings₹472.50m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 30, 2024

Earnings per share (EPS)100.53
Gross Margin63.00%
Net Profit Margin15.44%
Debt/Equity Ratio170.6%

How did 526783 perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

4%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.